{
  "trial_id": "NCT01929109",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), renal function (estimated creatinine clearance), presence of Type 2 Diabetes Mellitus (T2DM), blood pressure, hemoglobin levels, use of insulin, duration of hemodialysis, use of cytochrome P450 (CYP)3A inhibitors, use of drugs with a narrow therapeutic index, QT interval on ECG, PR interval on ECG.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Type 2 Diabetes Mellitus (T2DM) status",
          "presence of Type 2 Diabetes Mellitus (T2DM)"
        ],
        [
          "Creatinine clearance (CLcr)",
          "renal function (estimated creatinine clearance)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Estimated Glomerular Filtration Rate (eGRF)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "blood pressure",
        "hemoglobin levels",
        "use of insulin",
        "duration of hemodialysis",
        "use of cytochrome P450 (CYP)3A inhibitors",
        "use of drugs with a narrow therapeutic index",
        "QT interval on ECG",
        "PR interval on ECG."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Estimated Creatinine Clearance (CLcr), Renal Function Group (Healthy, Mild, Moderate, Severe, ESRD), Type 2 Diabetes Mellitus Status, Hemoglobin, Systolic Blood Pressure, Diastolic Blood Pressure, 12-lead Electrocardiogram (ECG) Abnormalities, Use of Potent CYP3A Inhibitors, Use of Drugs with Narrow Therapeutic Index, Use of Drugs Known to Prolong QT Interval,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Type 2 Diabetes Mellitus (T2DM) status",
          "Type 2 Diabetes Mellitus Status"
        ],
        [
          "Creatinine clearance (CLcr)",
          "Estimated Creatinine Clearance (CLcr)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Estimated Glomerular Filtration Rate (eGRF)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Renal Function Group (Healthy, Mild, Moderate, Severe, ESRD)",
        "Hemoglobin",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "12-lead Electrocardiogram (ECG) Abnormalities",
        "Use of Potent CYP3A Inhibitors",
        "Use of Drugs with Narrow Therapeutic Index",
        "Use of Drugs Known to Prolong QT Interval"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Estimated Creatinine Clearance, Diabetes Status, Hemoglobin, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Type 2 Diabetes Mellitus (T2DM) status",
          "Diabetes Status"
        ],
        [
          "Creatinine clearance (CLcr)",
          "Estimated Creatinine Clearance"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Estimated Glomerular Filtration Rate (eGRF)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Hemoglobin",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), estimated creatinine clearance (CLcr), presence of type 2 diabetes mellitus (T2DM), hemoglobin level, systolic and diastolic blood pressure, electrocardiogram (ECG) parameters (QTcF, PR interval).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Male",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Type 2 Diabetes Mellitus (T2DM) status",
          "presence of type 2 diabetes mellitus (T2DM)"
        ],
        [
          "Creatinine clearance (CLcr)",
          "estimated creatinine clearance (CLcr)"
        ]
      ],
      "remaining_reference_features": [
        "Estimated Glomerular Filtration Rate (eGRF)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "hemoglobin level",
        "systolic and diastolic blood pressure",
        "electrocardiogram (ECG) parameters (QTcF, PR interval)"
      ]
    }
  }
}